Sign In
Buy HIMS
$28.01
+0.500 (+1.82%)
At Close: Jun 04, 2026
SAN FRANCISCO, June 30, 2025 (GLOBE NEWSWIRE) -- On June 25, 2025, two securities class action lawsuits were filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of the company's executives
NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Bernstein Liebhard LLP, a nationally acclaimed investor rights law firm, reminds Hims & Hers Health, Inc. (“Hims” or the “Company”) (NYSE: HIMS) inv
Hims & Hers vs. LifeMD: Which Telehealth Stock Has More Upside?
11:15am, Monday, 30'th Jun 2025
HIMS and LFMD are surging in the telehealth race, but which one has stronger earnings growth and expansion momentum? Let's see.
Hims & Hers: You Are Missing The Big Picture
10:00am, Monday, 30'th Jun 2025
Novo Nordisk just killed the deal. But Hims might come out even stronger. Here's why the market got it wrong. GLP-1s are just the tip of the iceberg. Hims is quietly positioning itself as the gateway
Deadline Approaching: Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Urged to Contact Law Offices of Howard G. Smith
09:00am, Monday, 30'th Jun 2025
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming August 25, 2025 deadline to file a lead plaintiff motion in the case filed on behalf of investors who p
NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of
SAN DIEGO , June 30, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29,
Great News for Hims & Hers Stock Investors
05:15am, Monday, 30'th Jun 2025
Hims & Hers (HIMS 6.81%) stock investors desperately need some positive news following the stock price crash in late June.
SAN DIEGO, June 29, 2025 (GLOBE NEWSWIRE) -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Hims & Hers Health, Inc. (NYSE: HIMS) securities between April 29, 2025 and June
NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS). S
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Hims & Hers Health, Inc. - HIMS
10:00am, Saturday, 28'th Jun 2025
NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Hims & Hers Health, Inc. (“Hims & Hers” or the “Company”) (NYSE: HIMS). Such inv
HIMS Investors Have the Opportunity to Lead the Hims & Hers Health Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
09:05am, Saturday, 28'th Jun 2025
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Hims To Contact Him Directly To Discuss Their Options
Hims & Hers Stock Investors Need to Know This Before Buying or Selling This Growth Stock
08:00am, Saturday, 28'th Jun 2025
I am receiving several questions from investors inquiring about this growth stock following its significant price decline.
NEW YORK, June 28, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Hims & Hers Health, Inc. (NYSE: HIMS) and certain of
Hims & Hers Stock Financial Analysis Following Huge Stock Price Crash
07:30am, Saturday, 28'th Jun 2025
Hims & Hers (HIMS 6.81%) is attracting investors looking to buy the dip in this impressive growth stock.
